AroCell: Additional study shows use of TK1 concentration
Research Note
2019-09-19
12:42
An additional study on thymidine kinase 1 concentration further demonstrates its use for breast cancer therapay response. The results presented are important for the company to spread awareness of the method.
OB
Oscar Bergman
Disclosures and disclaimers